JP2024530050A5 - - Google Patents

Info

Publication number
JP2024530050A5
JP2024530050A5 JP2024508455A JP2024508455A JP2024530050A5 JP 2024530050 A5 JP2024530050 A5 JP 2024530050A5 JP 2024508455 A JP2024508455 A JP 2024508455A JP 2024508455 A JP2024508455 A JP 2024508455A JP 2024530050 A5 JP2024530050 A5 JP 2024530050A5
Authority
JP
Japan
Prior art keywords
hemisphere
patient
aav
acid sequence
aav vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/072487 external-priority patent/WO2023017098A2/en
Publication of JP2024530050A publication Critical patent/JP2024530050A/ja
Publication of JP2024530050A5 publication Critical patent/JP2024530050A5/ja
Pending legal-status Critical Current

Links

JP2024508455A 2021-08-11 2022-08-10 中枢神経系に影響を及ぼす障害の改善された治療のための組成物及び方法 Pending JP2024530050A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163232053P 2021-08-11 2021-08-11
US63/232,053 2021-08-11
US202263331614P 2022-04-15 2022-04-15
US63/331,614 2022-04-15
PCT/EP2022/072487 WO2023017098A2 (en) 2021-08-11 2022-08-10 Compositions and methods for improved treatment of disorders affecting the central nervous system

Publications (2)

Publication Number Publication Date
JP2024530050A JP2024530050A (ja) 2024-08-14
JP2024530050A5 true JP2024530050A5 (cg-RX-API-DMAC7.html) 2025-08-20

Family

ID=83232657

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508455A Pending JP2024530050A (ja) 2021-08-11 2022-08-10 中枢神経系に影響を及ぼす障害の改善された治療のための組成物及び方法

Country Status (6)

Country Link
US (1) US20240358794A1 (cg-RX-API-DMAC7.html)
EP (1) EP4384195A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024530050A (cg-RX-API-DMAC7.html)
AU (1) AU2022327583A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228916A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023017098A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117286119A (zh) * 2023-09-06 2023-12-26 复旦大学附属中山医院 可静脉注射给药的tpk表达病毒及其治疗阿尔茨海默病的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5541307A (en) 1990-07-27 1996-07-30 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs and solid phase synthesis thereof
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
ATE139900T1 (de) 1992-11-13 1996-07-15 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
AU4645697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Aav4 vector and uses thereof
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
DE69939169D1 (de) 1998-05-28 2008-09-04 Us Gov Health & Human Serv Aav5 vektoren und deren verwendung
DE69936104T2 (de) 1998-11-05 2008-01-17 The Trustees Of The University Of Pennsylvania Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
WO2004058166A2 (en) 2002-12-23 2004-07-15 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
US7561972B1 (en) 2008-06-06 2009-07-14 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
US7561973B1 (en) 2008-07-31 2009-07-14 Dna Twopointo, Inc. Methods for determining properties that affect an expression property value of polynucleotides in an expression system
US20130090374A1 (en) * 2011-04-20 2013-04-11 Miguel Sena-Esteves Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis
EP2620444B1 (en) 2012-01-30 2015-05-06 Nitto Denko Corporation Linker and support for solid phase synthesis of nucleic acid
TW202111127A (zh) * 2019-07-24 2021-03-16 美商航海家醫療公司 用於治療亨丁頓舞蹈症之組合物及方法
GB201913974D0 (en) * 2019-09-27 2019-11-13 King S College London Vector

Similar Documents

Publication Publication Date Title
US20220049272A1 (en) Gene therapy for juvenile batten disease
EP1879623B1 (en) Gene therapy for spinal cord disorders
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
US20250312400A1 (en) Intrathecal Delivery of Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2
RU2020109343A (ru) Полинуклеотиды aadc для лечения болезни паркинсона
KR20120006073A (ko) 신경변성 질환에 대한 유전자 요법
TW202417467A (zh) Aav蛋白殼變異體及其用途
Pignataro et al. Gene therapy approaches in the non-human primate model of Parkinson’s disease
JP2024539123A5 (cg-RX-API-DMAC7.html)
JP2021525245A5 (cg-RX-API-DMAC7.html)
JP2023500011A5 (cg-RX-API-DMAC7.html)
CN114126667A (zh) 使用糖苷水解酶的基因疗法载体向视网膜细胞的改进递送
CN114144518A (zh) 用于基因疗法的双亮氨酸拉链激酶抑制剂
CN119255814A (zh) 脑中bag3和蛋白质的质量控制
JP2024543253A5 (cg-RX-API-DMAC7.html)
Boespflug-Tanguy et al. Gene therapy for neurodegenerative disorders in children: dreams and realities
CN116390773A (zh) 用于通过基因疗法治疗诸如阿尔茨海默病的Tau蛋白病的病毒颗粒
JP2024515629A5 (cg-RX-API-DMAC7.html)
Miyake et al. Gene delivery into the central nervous system (CNS) using AAV vectors
US20230124994A1 (en) Compositions and methods for the treatment of sanfilippo disease and other disorders
JP2024530050A (ja) 中枢神経系に影響を及ぼす障害の改善された治療のための組成物及び方法
JP2023506007A (ja) パーキンソン病を治療するための方法
US20260002176A1 (en) Adeno-associated virus gene therapy products and methods
JP7826334B2 (ja) 髄腔内送達によってピット・ホプキンス症候群を治療するためのメチル-cpg結合タンパク質2をコードする組換えアデノ随伴ウイルス
JP2025510150A5 (cg-RX-API-DMAC7.html)